You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MEDI4920

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sjogren's Syndrome Trial (Dazodalibep, Placebo)

Not yet recruiting
  • Sjogren's Syndrome
  • (no location specified)
Oct 23, 2023

Rheumatoid Arthritis Trial in Poland, United States (VIB4920, Placebo)

Completed
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +24 more
Feb 15, 2022

Adult Onset Rheumatoid Arthritis Trial in Poland, United States (VIB4920, Placebo)

Completed
Has Results
  • Adult Onset Rheumatoid Arthritis
  • Anniston, Alabama
  • +11 more
Aug 12, 2019

Healthy Volunteer Trial in Leeds (MEDI4920 3 mg, MEDI4920 10 mg, MEDI4920 30 mg)

Completed
Has Results
  • Healthy Volunteer
  • MEDI4920 3 mg
  • +7 more
  • Leeds, United Kingdom
    Research Site
Oct 2, 2018

Allografts, Rejection; Transplant, Kidney, Transplant Rejection Trial in United States (Belatacept, VIB4920)

Active, not recruiting
  • Allografts
  • +3 more
  • Los Angeles, California
  • +3 more
Aug 11, 2022

Sjögren's Syndrome Trial in Worldwide (VIB4920, Placebo)

Recruiting
  • Sjögren's Syndrome
  • Fullerton, California
  • +58 more
Sep 30, 2021

Coronary Heart Disease (CHD) Trial in Worldwide (MEDI6570, Placebo)

Active, not recruiting
  • Coronary Heart Disease (CHD)
  • MEDI6570
  • Placebo
  • Mobile, Alabama
  • +93 more
Nov 22, 2022

Atherosclerosis, Cardiovascular Disease Trial in United States (MEDI6570, Placebo, Part B Placebo)

Completed
  • Atherosclerosis
  • Cardiovascular Disease
  • MEDI6570
  • +2 more
  • Anniston, Alabama
  • +8 more
Aug 21, 2020

B-cell Malignancies, Cancer Trial in Worldwide (MEDI-551, Rituximab)

Completed
Has Results
  • B-cell Malignancies
  • Cancer
  • Birmingham, Alabama
  • +20 more
Apr 29, 2020